RasGRP1 has been found to be upregulated in hepatocellular carcinomas (HCC) [105]; furthermore, a high RasGRP1 expression is associated with the tumor size, tumor–node–metastasis (TNM) stage, and Barcelona Clinic Liver Cancer stage [105]. This evidence concerns the gene RASGRP1 and liver cancer.